Art esp guidelines 8142

Preámbulo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Introducción . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 ¿Por qué necesitamos Guías de Práctica Clínica sobre valvulopatías? . . . . . . . . . . . . . . . 3 Contenido de estas Guías . . . . . . . . . . . . . . . . . 4 Cómo usar estas Guías . . . . . . . . . . . . . . . . . . . 4 Método de revisión . . . . . . . . . . . . . . . . . . . . . . 4 Definición de las clases de recomendaciones . . 5 Comentarios generales . . . . . . . . . . . . . . . . . . . . . 5 Evaluación del paciente . . . . . . . . . . . . . . . . . . . 5 Evaluación clínica . . . . . . . . . . . . . . . . . . . . . 5 Ecocardiografía . . . . . . . . . . . . . . . . . . . . . . . 5 Fluoroscopia . . . . . . . . . . . . . . . . . . . . . . . . . 7 Angiografía con radionúclidos . . . . . . . . . . . 7 Pruebas de esfuerzo . . . . . . . . . . . . . . . . . . . . 7 Otras técnicas de imagen no invasivas . . . . . 7 Biomarcadores . . . . . . . . . . . . . . . . . . . . . . . . 7 Coronariografía . . . . . . . . . . . . . . . . . . . . . . . 7 Cateterización cardiaca . . . . . . . . . . . . . . . . . 8 Evaluación de comorbilidades . . . . . . . . . . . . 8 Profilaxis de la endocarditis . . . . . . . . . . . . . 8 Estratificación del riesgo . . . . . . . . . . . . . . . . . . 8 Insuficiencia aórtica . . . . . . . . . . . . . . . . . . . . . . . 8 Introducción . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Evaluación . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Guía de práctica clínica sobre el tratamiento de las valvulopatías

[1]  Werner Klein,et al.  Management of Grown Up Congenital Heart Disease The Task Force on the Management of Grown Up Congenital Heart Disease of the European Society of Cardiology , 2003 .

[2]  C. Guglielmi,et al.  Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. , 2004, The Annals of thoracic surgery.

[3]  S. Bolling,et al.  Update on Mitral Repair in Dilated Cardiomyopathy , 2004, Journal of cardiac surgery.

[4]  A. Tajik,et al.  Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. , 2000, Circulation.

[5]  M. Enriquez-Sarano,et al.  Quantitative determinants of the outcome of asymptomatic mitral regurgitation. , 2005, The New England journal of medicine.

[6]  E. Schwammenthal,et al.  Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. , 2005, Circulation.

[7]  C. Gohlke-Bärwolf,et al.  Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery , 2000, Heart.

[8]  M. Makris,et al.  The management of coumarin‐induced over‐anticoagulation , 2001 .

[9]  C. Paré,et al.  Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías , 2000 .

[10]  M. Enriquez-Sarano,et al.  B-Type Natriuretic Peptide in Organic Mitral Regurgitation: Determinants and Impact on Outcome , 2005, Circulation.

[11]  A Starr,et al.  Actuarial versus actual risk of porcine structural valve deterioration. , 1994, The Journal of thoracic and cardiovascular surgery.

[12]  R. Devereux,et al.  Natural history of mitral valve prolapse. , 1995, The American journal of cardiology.

[13]  Hui-hua Li,et al.  Better anticoagulation control improves survival after valve replacement. , 2002, The Journal of thoracic and cardiovascular surgery.

[14]  B. Iung Management of ischaemic mitral regurgitation , 2003, Heart.

[15]  P. Tornos,et al.  Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol , 2003, Heart.

[16]  Andreas Franke,et al.  Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. , 2003, Journal of the American College of Cardiology.

[17]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[18]  H. Rimington,et al.  Exercise testing to stratify risk in aortic stenosis. , 2005, European heart journal.

[19]  K. Weber,et al.  Functional Valvular Incompetence in Decompensated Heart Failure: Noninvasive Monitoring and Response to Medical Management , 2005, The American journal of the medical sciences.

[20]  Patrick Royston,et al.  Generic, Simple Risk Stratification Model for Heart Valve Surgery , 2005, Circulation.

[21]  A. Carpentier,et al.  Cardiac valve surgery--the "French correction". , 1983, The Journal of thoracic and cardiovascular surgery.

[22]  T. Shaw,et al.  Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over , 2000, Heart.

[23]  Jeroen J. Bax,et al.  Restrictive Annuloplasty and Coronary Revascularization in Ischemic Mitral Regurgitation Results in Reverse Left Ventricular Remodeling , 2004, Circulation.

[24]  M. Enriquez-Sarano,et al.  Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. , 2003, Circulation.

[25]  K. Bailey,et al.  Ischemic Mitral Regurgitation: Long-Term Outcome and Prognostic Implications With Quantitative Doppler Assessment , 2001, Circulation.

[26]  M. Enriquez-Sarano,et al.  Clinical practice. Aortic regurgitation. , 2004, The New England journal of medicine.

[27]  M. Enriquez-Sarano,et al.  Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. , 1997, Journal of the American College of Cardiology.

[28]  J. Bavaria,et al.  Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. , 2000, Circulation.

[29]  S. Armstrong,et al.  The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[30]  S. Pauker,et al.  Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[31]  R. Scognamiglio,et al.  Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. , 2005, Journal of the American College of Cardiology.

[32]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[33]  C. Otto,et al.  Timing of surgery in asymptomatic mitral regurgitation. , 2005, The New England journal of medicine.

[34]  S. Hammami,et al.  Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. , 1998, Circulation.

[35]  A. Fraser,et al.  A New Scoring System to Determine Thromboembolic Risk After Heart Valve Replacement , 2003, Circulation.

[36]  S. Rahimtoola,et al.  Prosthetic Heart Valves and Pregnancy , 2003, Circulation.

[37]  M. Lauer,et al.  Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. , 2002, Journal of the American College of Cardiology.

[38]  M. Buyse,et al.  Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials. , 1995, The Journal of thoracic and cardiovascular surgery.

[39]  A. Evangelista,et al.  Long-term vasodilator therapy in patients with severe aortic regurgitation. , 2005, The New England journal of medicine.

[40]  R. Tait,et al.  Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. , 2001, Archives of internal medicine.

[41]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.

[42]  H. Schaff,et al.  Low-Output, Low-Gradient Aortic Stenosis in Patients With Depressed Left Ventricular Systolic Function: The Clinical Utility of the Dobutamine Challenge in the Catheterization Laboratory , 2002, Circulation.

[43]  M. Ajuria,et al.  Carpentier's flexible ring versus De Vega's annuloplasty. A prospective randomized study. , 1985, The Journal of thoracic and cardiovascular surgery.

[44]  A. Pezzano,et al.  Measurement of mitral valve area in mitral stenosis: four echocardiographic methods compared with direct measurement of anatomic orifices. , 1996, Journal of the American College of Cardiology.

[45]  S. Rahimtoola,et al.  Choice of prosthetic heart valve for adult patients. , 2003, Journal of the American College of Cardiology.

[46]  A. Battler,et al.  Value of exercise echocardiography in rheumatic mitral stenosis with and without significant mitral regurgitation. , 2004, The American journal of cardiology.

[47]  J B Seward,et al.  Clinical outcome of mitral regurgitation due to flail leaflet. , 1996, The New England journal of medicine.

[48]  F. Carreras,et al.  Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. , 2003, Journal of the American College of Cardiology.

[49]  R. Abbate,et al.  Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real‐practice of an anticoagulation clinic , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[50]  R. D'amico,et al.  Comparing Warfarin With Aspirin After Biological Aortic Valve Replacement: A Prospective Study , 2004, Circulation.

[51]  R. Arnoni,et al.  Risk factors associated with cardiac surgery during pregnancy. , 2003, The Annals of thoracic surgery.

[52]  M. Wahl Dental surgery in anticoagulated patients. , 1998, Archives of internal medicine.

[53]  M. Enriquez-Sarano,et al.  Sudden death in mitral regurgitation due to flail leaflet. , 1999, Journal of the American College of Cardiology.

[54]  L. Shapiro,et al.  Superiority of mitral valve repair in surgery for degenerative mitral regurgitation. , 1997, European heart journal.

[55]  P. Stein Antithrombotic therapy in valvular heart disease. , 2001, Clinics in geriatric medicine.

[56]  J. Labèque,et al.  Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. , 2004, Journal of the American College of Cardiology.

[57]  J. Harnek,et al.  Percutaneous Transvenous Mitral Annuloplasty: Initial Human Experience With Device Implantation in the Coronary Sinus , 2006, Circulation.

[58]  G. Vlahakes,et al.  Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. , 1998, The Annals of thoracic surgery.

[59]  M. Schemper,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis. , 2000, The New England journal of medicine.

[60]  E. Mohler Mechanisms of aortic valve calcification. , 2004, The American journal of cardiology.

[61]  J. Bermejo,et al.  Clinical efficacy of Doppler-echocardiographic indices of aortic valve stenosis: a comparative test-based analysis of outcome. , 2003, Journal of the American College of Cardiology.

[62]  M. Carrier,et al.  Results following valve replacement for ischemic mitral regurgitation. , 2001, The Canadian journal of cardiology.

[63]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[64]  Rolf Fimmers,et al.  Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study , 2003, The Lancet.

[65]  P. Kligfield,et al.  Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. , 1998, Circulation.

[66]  M. Okada,et al.  Long-term evaluation of treatment for functional tricuspid regurgitation with regurgitant volume: characteristic differences based on primary cardiac lesion. , 1999, The Journal of thoracic and cardiovascular surgery.

[67]  A. Laupacis,et al.  A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. , 1993, The New England journal of medicine.

[68]  John A Elefteriades,et al.  Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. , 2002, The Annals of thoracic surgery.

[69]  S. Siu,et al.  Risk and predictors for pregnancy-related complications in women with heart disease. , 1996, Circulation.

[70]  Y. Ko,et al.  Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study , 1998, Annals of Internal Medicine.

[71]  C. Otto,et al.  Timing of aortic valve surgery , 2000, Heart.

[72]  P. Presbitero,et al.  Interventional cardiology in pregnancy. , 1996, European heart journal.

[73]  W G Henderson,et al.  Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. , 2000, Journal of the American College of Cardiology.

[74]  R. Moss,et al.  Injection drug use and right sided endocarditis , 2003, Heart.

[75]  M. Antunes,et al.  Open mitral commissurotomy: the 'golden standard'. , 2000, The Journal of heart valve disease.

[76]  L. Cohn,et al.  Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. , 2004, Journal of the American College of Cardiology.

[77]  Bonnie K. Lind,et al.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.

[78]  V. Fuster,et al.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. , 1983, The American journal of cardiology.

[79]  B. Iung,et al.  Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. , 2000, The American journal of cardiology.

[80]  L. Menicanti,et al.  Moderate ischemic mitral regurgitation and coronary artery bypass surgery: effect of mitral repair on clinical outcome. , 2003, The Journal of heart valve disease.

[81]  N. Sinha,et al.  Noncoronary cardiac interventions. The 3rd report of the Non-Coronary Cardiac Interventions Registry of India. The Cardiological Society of India. , 2003, Indian heart journal.

[82]  E. DeLong,et al.  Prediction of operative mortality after valve replacement surgery. , 2001, Journal of the American College of Cardiology.

[83]  J. Bonnet,et al.  Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. , 2000, Journal of the American College of Cardiology.

[84]  E. Murphy,et al.  Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. , 1994, The New England journal of medicine.

[85]  E. Prystowsky,et al.  Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. , 2005, Chest.

[86]  C. O'connor,et al.  Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. , 2003, The American journal of cardiology.

[87]  M. O'Brien,et al.  The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. , 2001, The Journal of heart valve disease.

[88]  M. Enriquez-Sarano,et al.  Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function , 2002, Circulation.

[89]  U. Elkayam,et al.  The effect of valvular heart disease on maternal and fetal outcome of pregnancy. , 2001, Journal of the American College of Cardiology.

[90]  T. Marwick,et al.  Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation , 2005, Heart.

[91]  D J Wheatley,et al.  Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses , 2003, Heart.

[92]  C. Yancy,et al.  Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. , 1995, The American journal of cardiology.

[93]  J. Garot,et al.  Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes diagnostic accuracy and outcome implications. , 2005, Journal of the American College of Cardiology.

[94]  N. Boon,et al.  The medical management of valvar heart disease , 2002, Heart.

[95]  M. Enriquez-Sarano,et al.  Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study. , 2000, Journal of the American College of Cardiology.

[96]  K. E. Werner,et al.  Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing , 2001, Heart.

[97]  L. Shaw,et al.  Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. , 2005, The Journal of thoracic and cardiovascular surgery.

[98]  J. O’Keefe,et al.  Risk of noncardiac surgical procedures in patients with aortic stenosis. , 1989, Mayo Clinic proceedings.

[99]  D. Fitzmaurice,et al.  Recommendations for patients undertaking self management of oral anticoagulation , 2001, BMJ : British Medical Journal.

[100]  C. Tribouilloy,et al.  Low‐Gradient Aortic Stenosis Operative Risk Stratification and Predictors for Long‐Term Outcome: A Multicenter Study Using Dobutamine Stress Hemodynamics , 2003, Circulation.

[101]  B Cormier,et al.  Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. , 1996, Circulation.

[102]  E. Foster,et al.  Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. , 2005, Journal of the American College of Cardiology.

[103]  F. Rosendaal,et al.  Oral anticoagulation in surgical procedures: risks and recommendations , 2003, British journal of haematology.

[104]  James B. Seward,et al.  Quantitative Doppler Assessment of Valvular Regurgitation , 1993, Circulation.

[105]  D. Brown,et al.  Risk of patients with severe aortic stenosis undergoing noncardiac surgery. , 1998, The American journal of cardiology.

[106]  K. Nath,et al.  Marfan's syndrome. , 1959, Journal of the Indian Medical Association.

[107]  I. Palacios,et al.  Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy. , 1996, Journal of the American College of Cardiology.

[108]  H. Warembourg,et al.  Recommandations de la Société française de cardiologie concernant la prise en charge des valvulopathies acquises et des dysfonctions de prothèse valvulaire , 2005 .

[109]  S. Skates,et al.  Clinical Predictors of Prolonged Delay in Return of the International Normalized Ratio to within the Therapeutic Range after Excessive Anticoagulation with Warfarin , 2001, Annals of Internal Medicine.

[110]  C M Otto,et al.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.

[111]  R. Bergström,et al.  Observed and relative survival after aortic valve replacement. , 2000, Journal of the American College of Cardiology.

[112]  R. Siegel,et al.  Ischemic mitral regurgitation: revascularization alone versus revascularization and mitral valve repair. , 2005, The Annals of thoracic surgery.

[113]  A. Turpie,et al.  Perioperative management of patients receiving oral anticoagulants: a systematic review. , 2003, Archives of internal medicine.

[114]  M. Schemper,et al.  Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation , 2006, Circulation.

[115]  B. Iung,et al.  Percutaneous mitral commissurotomy for restenosis after surgical commissurotomy: late efficacy and implications for patient selection. , 2000, Journal of the American College of Cardiology.

[116]  A. DeMaria,et al.  Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases. , 2003, Journal of the American College of Cardiology.

[117]  Dieter zur Nedden,et al.  Multislice computed tomography for detection of patients with aortic valve stenosis and quantification of severity. , 2006, Journal of the American College of Cardiology.

[118]  L. Cohn,et al.  Long-term outcomes of tricuspid valve replacement in the current era. , 2005, The Annals of thoracic surgery.

[119]  U. Elkayam,et al.  Valvular heart disease and pregnancy: part II: prosthetic valves. , 2005, Journal of the American College of Cardiology.

[120]  Jeroen J. Bax,et al.  Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. , 2004, The American journal of medicine.

[121]  M. Enriquez-Sarano,et al.  Evaluation and Clinical Implications of Aortic Valve Calcification Measured by Electron-Beam Computed Tomography , 2004, Circulation.

[122]  I. Palacios,et al.  Which Patients Benefit From Percutaneous Mitral Balloon Valvuloplasty?: Prevalvuloplasty and Postvalvuloplasty Variables That Predict Long-Term Outcome , 2002, Circulation.

[123]  M. Enriquez-Sarano,et al.  Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. , 1999, Circulation.

[124]  B. Iung,et al.  Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism. , 1993, The Journal of heart valve disease.

[125]  B. Lytle,et al.  Is repair preferable to replacement for ischemic mitral regurgitation? , 2001, The Journal of thoracic and cardiovascular surgery.

[126]  M. Lane,et al.  Pulmonary autograft in children: realized growth potential. , 1994, The Annals of thoracic surgery.

[127]  J. McCullough,et al.  Surgical treatment of the dilated ascending aorta: when and how? , 1999, The Annals of thoracic surgery.

[128]  G. Thiene,et al.  Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[129]  G Chatellier,et al.  Very Long-Term Results (More Than 20 Years) of Valve Repair With Carpentier’s Techniques in Nonrheumatic Mitral Valve Insufficiency , 2001, Circulation.

[130]  M. Borger,et al.  Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? , 2004, The Journal of thoracic and cardiovascular surgery.

[131]  S. Thorne Pregnancy in heart disease , 2004, Heart.

[132]  T. Kural,et al.  Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. , 1996, The American journal of cardiology.

[133]  M. Enriquez-Sarano,et al.  Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. , 1999, Circulation.

[134]  A. Friedl,et al.  Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: analysis of the GELIA Database (GELIA 4) , 2001 .

[135]  J. Soler‐Soler,et al.  Worldwide perspective of valve disease , 2000, Heart.

[136]  S. Steinhubl,et al.  Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. , 2004, American heart journal.

[137]  M. G. St. John Sutton Predictors of long-term survival after valve replacement for chronic aortic regurgitation. , 2001, European heart journal.

[138]  Philippe Ravaud,et al.  Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? , 2005, European heart journal.

[139]  M. Enriquez-Sarano,et al.  Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. , 2002, Journal of the American College of Cardiology.

[140]  O. K. Hansen,et al.  Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. , 1996, The Thoracic and cardiovascular surgeon.

[141]  S. Bolling,et al.  Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. , 2005, Journal of the American College of Cardiology.

[142]  F. Schoendube,et al.  Combined mitral valve and coronary artery surgery: ischemic versus non-ischemic mitral valve disease. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[143]  T. Sundt,et al.  Surgery for Aneurysms of the Aortic Root: A 30-Year Experience , 2004, Circulation.

[144]  Jeroen J. Bax,et al.  Accurate quantitation of regurgitant volume with MRI in patients selected for mitral valve repair. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[145]  D C Naftel,et al.  Long-term performance of heart valve prostheses. , 2000, Current problems in cardiology.

[146]  J. Repke,et al.  A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. , 1995, American journal of obstetrics and gynecology.

[147]  Henry Krum,et al.  The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). , 2005, European heart journal.

[148]  Homer Yang,et al.  Patients with aortic stenosis: Cardiac complications in non-cardiac surgery , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[149]  M. Budoff,et al.  Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. , 2005, Archives of internal medicine.

[150]  B. Iung,et al.  AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. , 1996, Circulation.

[151]  G. Dreyfus,et al.  Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? , 2005, The Annals of thoracic surgery.

[152]  W. Likoff,et al.  Valvular Heart Disease , 2018, The Perioperative Medicine Consult Handbook.

[153]  Samuel Wann,et al.  [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.

[154]  P. Grayburn Vasodilator therapy for chronic aortic and mitral regurgitation. , 2000, The American journal of the medical sciences.

[155]  V. Fuster,et al.  Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. , 1997, Journal of the American College of Cardiology.

[156]  S. Goldhaber,et al.  The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. , 2005, American heart journal.

[157]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[158]  Bonnie K. Lind,et al.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999, The New England journal of medicine.

[159]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[160]  J. Almeida Intermediate-term outcome of mitral reconstruction in cardiomyopathy. , 1999, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[161]  L. Pierard,et al.  Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. , 2001, Journal of the American College of Cardiology.

[162]  B. Iung,et al.  Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. , 1999, Circulation.

[163]  B. Griffin,et al.  Choosing the most appropriate valve operation and prosthesis. , 2002, Cleveland Clinic journal of medicine.

[164]  S. Hussain,et al.  Management of mitral paravalvular leak: therapy or misadventure? , 2003, The Journal of thoracic and cardiovascular surgery.

[165]  I. Palacios,et al.  Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. , 1988, British heart journal.

[166]  S. Nashef,et al.  Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. , 2001, The Journal of heart valve disease.

[167]  B. McCrindle,et al.  Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. , 2005, The American journal of cardiology.

[168]  D. Massel,et al.  Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. , 2001, Journal of the American College of Cardiology.

[169]  M. Enriquez-Sarano,et al.  Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. , 1995, Circulation.

[170]  M. Enriquez-Sarano,et al.  Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical correction. , 1996, Journal of the American College of Cardiology.

[171]  C. Russo,et al.  Tricuspid Regurgitation Secondary to Mitral Valve Disease: Tricuspid Annulus Function as Guide to Tricuspid Valve Repair , 2001, Cardiovascular surgery.

[172]  J. Sharma,et al.  Maternal and fetal outcome in valvular heart disease , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[173]  R. Devereux,et al.  Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. , 1995, Journal of the American College of Cardiology.

[174]  R. Bonow,et al.  Contemporary approach to aortic and mitral regurgitation. , 2003, Circulation.

[175]  J. Ramires,et al.  Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. , 2003, Journal of the American College of Cardiology.

[176]  P. Kligfield,et al.  Aortic root dilatation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function. , 1987, Annals of internal medicine.

[177]  R. Levine,et al.  American Society of Echocardiography: recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography , 2003 .

[178]  M. Simon,et al.  Prognostic Importance of Quantitative Exercise Doppler Echocardiography in Asymptomatic Valvular Aortic Stenosis , 2005, Circulation.

[179]  A. John Camm,et al.  The Esc Textbook of Cardiovascular Medicine , 2009 .

[180]  W. Chan,et al.  Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. , 2000, Archives of internal medicine.

[181]  R. Hall,et al.  Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology. , 1993, The Journal of heart valve disease.

[182]  G. Baron,et al.  Temporal trends in percutaneous mitral commissurotomy over a 15-year period. , 2004, European heart journal.

[183]  S. Kiatchoosakun,et al.  Resolution of Left Atrial Thrombus after 6 Months of Anticoagulation in Candidates for Percutaneous Transvenous Mitral Commissurotomy , 2004, Annals of Internal Medicine.

[184]  B. Griffith,et al.  Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened. , 2005, Journal of the American College of Cardiology.

[185]  Mario J. Garcia,et al.  Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. , 2005, The American journal of medicine.

[186]  M. Lachat,et al.  Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[187]  Alec Vahanian,et al.  Percutaneous Approaches to Valvular Disease , 2004, Circulation.

[188]  R. Hall,et al.  Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. , 1995, European heart journal.

[189]  K. Bailey,et al.  Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up , 2005, Circulation.

[190]  I. Angin Impact of Preoperative Symptoms on Survival after Surgical Correction of Organic Mitral Regurgitation , 1999 .

[191]  O. Sancaktar,et al.  Late results of combined percutaneous balloon valvuloplasty of mitral and tricuspid valves. , 1998, Catheterization and cardiovascular diagnosis.

[192]  Y. Adler,et al.  Tricuspid regurgitation late after mitral valve replacement: clinical and echocardiographic evaluation. , 1999, The Journal of heart valve disease.

[193]  L. Pierard,et al.  Prognostic Importance of Exercise-Induced Changes in Mitral Regurgitation in Patients With Chronic Ischemic Left Ventricular Dysfunction , 2003, Circulation.

[194]  P. Pibarot,et al.  Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. , 2000, Journal of the American College of Cardiology.

[195]  M. Schemper,et al.  Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis , 2004, Circulation.

[196]  Jeroen J. Bax,et al.  Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.